A much-needed new way to inactivate GPCRs, the most common drug targets

About one-third of all drugs approved by the U.S. Food and Drug Administration target G protein-coupled receptors (GPCRs), a family of more than 800 cell-surface receptors that regulate a wide range of vital functions, including blood pressure, heart rate and immunity.